Injectable glucose sensor component matches pricier alternative at one-tenth the cost

For millions of people living with diabetes, continuous glucose monitors provide a real-time picture of glucose levels, helping users manage medication, diet and day-to-day activities.

Researchers at Texas A&M University have taken a step toward addressing that challenge by identifying a lower-cost component for an experimental injectable glucose sensor. In a study published in ACS Measurement Science Au, the team demonstrated that a sensing material costing roughly one-tenth as much as a commonly used alternative delivered similar performance.

Lower cost without sacrificing performance

The work centers on a nonenzymatic glucose-sensing platform that uses fluorescent molecules to measure glucose concentrations. Unlike many glucose-monitoring systems that rely on enzymes, the Texas A&M approach uses near-infrared fluorescence, allowing researchers to track changes in glucose levels through changes in light signals.

Sign up for Blog Updates